Share with others:
Another blow to Apple smartwatches over patent infringement
There have been many accusations of one company copying another's products and features. These claims are probably true to some extent, as everyone wants to offer their customers the best end product with all possible features. In particular, the company Apple stands out here, which has been repeatedly accused and even convicted for the unauthorized use of registered patents, as it fights with all its might to acquire as many customers as possible for its products, despite its own lack of innovation.
At the end of last December, the US International Trade Commission (ITC) took action against Apple due to the unauthorized use of registered technology. Apple allegedly infringed two out of a total of five patents for measuring blood oxygen saturation (SPO2) by Masimo. As of December 24, Apple has been banned from selling the Apple Watch Series 9 and Ultra 2 smartwatches in the United States. The aforementioned sales ban applied to both online and physical stores.
Even before the end of last year, Apple managed to obtain a temporary injunction to end the ban on the import and sale of smart watches in the United States. The court ordered that Apple can continue selling the aforementioned watches until the company receives an answer as to whether the proposed changes are enough to comply with the patented technology. But since that didn't happen, Apple was dealt another blow.
Due to the failed agreements with the Masimo company, Apple has started removing the ability to measure blood oxygen saturation (SPO2) from American owners of the Apple Watch 9 and Ultra 2 smart watches. This is what Apple is doing by updating the software code for its latest smartwatches. The new watches, which will be sold in online and physical stores, will already be available without the possibility of measuring blood oxygen saturation (SPO2). It is currently unknown how the new restriction will affect sales of Apple smartwatches in the US market. However, many are convinced that the decline in sales will be negligible.
